{"disease":{"id":"urinary-tract-infection-uti","name":"urinary tract infection uti"},"drugs":{"marketed":[{"drug_id":"zavicefta-ceftazidime-avibactam","indication_name":"Complicated urinary tract infections (cUTI), including pyelonephritis, caused by certain susceptible bacteria.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zavicefta, Ceftazidime-Avibactam","generic_name":"zavicefta-ceftazidime-avibactam","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Bacterial cell wall synthesis","drug_class":"Cephalosporin antibiotic and beta-lactamase inhibitor combination","quality_score":55,"revenue":"638","mechanism":""},{"drug_id":"relebactam","indication_name":"Complicated Urinary Tract Infections (cUTI), including Pyelonephritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"atm-avi","indication_name":"Treatment of uncomplicated urinary tract infections (UTIs) caused by Escherichia coli.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"atm-avi","indication_name":"Treatment of uncomplicated urinary tract infections (UTIs) caused by Klebsiella pneumoniae.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"atm-avi","indication_name":"Treatment of uncomplicated urinary tract infections (UTIs) caused by Escherichia coli in patients who have a penicillin tolerance test result of >= 20 mcg/mL.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"atm-avi","indication_name":"Treatment of uncomplicated urinary tract infections (UTIs) caused by Klebsiella pneumoniae in patients who have a penicillin tolerance test result of >= 20 mcg/mL.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03697096","title":"The INSPIRE-ASP UTI Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":55412,"lead_sponsor_name":"Harvard Pilgrim Health Care","has_results":true},{"nct_id":"NCT07233837","title":"Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT07012421","title":"Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"St George's, University of London","has_results":false},{"nct_id":"NCT06996301","title":"Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.","phase":"NA","overall_status":"COMPLETED","enrollment_count":773,"lead_sponsor_name":"Doc Lab Inc","has_results":true},{"nct_id":"NCT05887908","title":"Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":614,"lead_sponsor_name":"Meiji Seika Pharma Co., Ltd.","has_results":true},{"nct_id":"NCT06885658","title":"Effectiveness of Visual Storytelling Intervention on Antibiotic Adherence in UTI Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT07246837","title":"Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT07189429","title":"Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Sysmex Europe GmbH","has_results":false},{"nct_id":"NCT07191041","title":"Emotional Urinary Tract Infection","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT02714595","title":"Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT02728089","title":"Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04215991","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Shionogi","has_results":false},{"nct_id":"NCT06940622","title":"A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT01970371","title":"A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Achaogen, Inc.","has_results":true},{"nct_id":"NCT03270540","title":"Abdominal Ultrasonography in Urinary Tract Infection - When and Why?","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT07424989","title":"Antibiotic Therapies for Urinary Tract Infections and Their Impact on the Gut Microbiota","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT04335539","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT07233473","title":"Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Karo Pharma AB","has_results":false},{"nct_id":"NCT02623179","title":"Conventional and Molecular Diagnostic Method for Patients With Suspected UTI","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Southwest Regional PCR, LLC","has_results":false},{"nct_id":"NCT06719115","title":"A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"KEB Nutraceuticals USA, Inc.","has_results":false},{"nct_id":"NCT03644966","title":"Probiotics and Multi-Drug Resistant Urinary Tract Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Ochsner Health System","has_results":false},{"nct_id":"NCT04476407","title":"Pharmacokinetics of Benapenem in Subjects With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Sihuan Pharmaceutical Holdings Group Ltd.","has_results":false},{"nct_id":"NCT07432763","title":"Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Panhellenic Federation of Alzheimer's Disease and Related Disorders","has_results":false},{"nct_id":"NCT04496726","title":"Cranberry and Quillaja on Symptoms of Uncomplicated UTI","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT02637986","title":"The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"HaEmek Medical Center, Israel","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}